Innovative Prescription Drug Developers

Own drug developers whose commercial medicines fund research into new treatments, rather than healthcare distributors, insurers or equipment suppliers. With technology shares under pressure and several basket companies approaching earnings, prescription-drug franchises offer a different source of demand and company-specific catalysts. The basket combines established cash-generating businesses with pipeline exposure, while retaining clinical, patent-expiry and reimbursement risks. Launch basket (equal weight): ABBV, AMGN, MRK, LLY, MRNA, GILD, VRTX Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.